Drug intelligence / Profile preview

AMPK gene therapy (Integrated Health Systems)

Development stage
Preclinical
Lead developer
Integrated Healthcare Systems
Modality
Gene Therapies
Administration
Intravenous, Intramuscular
01

Overview

AMPK gene therapy is a regenerative medicine intervention developed by Integrated Health Systems (IHS). It involves the upregulation or activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. By increasing AMPK signaling, the therapy aims to enhance glucose metabolism, improve mitochondrial efficiency, and balance nutrient supply with energy demand. It is positioned as a preventative treatment for metabolic dysfunction and various age-related conditions, focusing on slowing or reversing the aging process at a cellular level. Unlike traditional pharmaceuticals, this therapy is offered as part of a medical concierge service specializing in anti-aging and regenerative treatments.

Other names
AMP-activated protein kinase activation gene therapyAMPK activationAMPK gene therapy
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on AMPK gene therapy (Integrated Health Systems).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMPK gene therapy (Integrated Health Systems).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call